http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2791891-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c275038cf36535d44a526cb28203c03d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caabef24a8eb35f40102146cdb52ff7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bb38e72cdab0bce9cc77c1049597f78
publicationDate 2000-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2791891-A1
titleOfInvention USE OF TIANEPTINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF NEURODEGENERESCENCE CONDITIONS
abstract The invention relates to the use of Tianeptine or its enantiomers for obtaining medicaments useful in the treatment of pathologies of neurodegeneration.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1755614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1755614-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8198268-B2
priorityDate 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2635461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2716623-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4698
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID327714
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25488
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID541328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508781
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8618362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3538
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40469935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1221
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID68202
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487551

Total number of triples: 59.